Therapeutic Strategies for Cardiovascular-Kidney-Metabolic Syndrome: Addressing the Interwoven Triad of Heart Failure, Chronic Kidney Disease, and Diabetes
Webcast
1 AAPA ...OVERVIEW
Therapeutic Strategies for Cardiovascular-Kidney-Metabolic Syndrome: Addressing the Interwoven Triad of Heart Failure, Chronic Kidney Disease, and Diabetes is organized by Healio, Medical Learning Institute, LLC.
CE Activity Release Date: January 6, 2025
CE Activity Expiration Date: January 5, 2026
Description:
Delve into the cutting-edge world of Cardiovascular-Kidney-Metabolic (CKM) Syndrome management in this CKM Dialogues previously recorded LIVE. This dynamic, expert-led, evidence-driven CME activity sheds light on the latest strategies for tackling CKM syndrome—a complex condition at the intersection of heart failure, chronic kidney disease, and type 2 diabetes. While individual guidelines exist for each disease, comprehensive guidance on managing their overlap is limited. CKM Dialogues LIVE brings together a multidisciplinary team of experts to bridge this gap with real-world insights and discussions on emerging therapies.
Educational Objectives:
After completing this CE activity, the participant should be better able to:
- Describe the complex interplay between CKD, HF, and T2D in the context of cardiovascular-kidney-metabolic syndrome.
- Analyze the epidemiological trends and pathophysiological mechanisms underlying the interconnectedness of HF, CKD, and T2D, and their implications for patient prognosis and quality of life.
- Evaluate the current evidence base supporting emerging therapeutic strategies, including sodium-glucose cotransporter 2 (SGLT2) inhibitors and aldosterone synthase inhibitors (ASIs), for managing cardiovascular-kidney-metabolic syndrome, with a focus on their potential to mitigate morbidity and mortality.
- Formulate evidence-based treatment plans for patients with cardiovascular-kidney-metabolic syndrome that consider the complex interactions between HF, CKD, and T2D to enhance patient quality of life.
ACCREDITATION & CREDITS
Credits:
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education:
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
EBAC Credit:
EBAC logoMedical Learning Institute Inc is an EBAC® accredited provider effective October 2023. EBAC holds an agreement on mutual recognition of substantial equivalency with the Accreditation Council of CME (ACCME) and converts certificates for live educational events in the US, issued by ACCME accredited providers to European participants, in EBAC certificates (on request of the participants).
Dietitian Continuing Professional Education Units (CPEUs):
Medical Learning Institute Inc is a Continuing Professional Education (CPE) Accredited provider with the Commission on Dietetic Registration (CDR).
Completion of this RD/DTR profession specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60-minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.
CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activity/material.
PA:
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) toward AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until January 5, 2026. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development:
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 0.5 contact hour in the area of pharmacology.
Continuing Pharmacy Education:
Medical Learning Institute Inc designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
TARGET AUDIENCE
PhysicianCardiologistsPrimary Care PhysiciansSPECIALITIES
CardiologyEndocrinologyNephrology
Quick Links